Citation Impact
Citing Papers
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
2018 Standout
Crippling life support for SARS-CoV-2 and other viruses through synthetic lethality
2020 StandoutNobel
Influenza Burden of Illness
2002
Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
2005 Standout
Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults
2007 Standout
Early treatment with baloxavir marboxil in high-risk adolescent and adult outpatients with uncomplicated influenza (CAPSTONE-2): a randomised, placebo-controlled, phase 3 trial
2020
The role of respiratory viruses in cystic fibrosis
2008
Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes
2002
Antiviral Therapy and Outcomes of Influenza Requiring Hospitalization in Ontario, Canada
2007
Influenza-Associated Hospitalizations in the United States
2004 Standout
Small-Vessel Vasculitis
1997 Standout
Antivirals for influenza in healthy adults: systematic review
2006
An HSV-2 Trivalent Vaccine Is Immunogenic in Rhesus Macaques and Highly Efficacious in Guinea Pigs
2017
Two Birds with One Stone? Possible Dual-Targeting H1N1 Inhibitors from Traditional Chinese Medicine
2011
Efficacy Results of a Trial of a Herpes Simplex Vaccine
2012
Antiviral Agents: Characteristic Activity Spectrum Depending on the Molecular Target With Which They Interact
1993
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Impact of Oseltamivir Treatment on Influenza-Related Lower Respiratory Tract Complications and Hospitalizations
2003
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Live Attenuated versus Inactivated Influenza Vaccine in Infants and Young Children
2007 Standout
Strategies for containing an emerging influenza pandemic in Southeast Asia
2005 StandoutNature
CATHETER-ASSOCIATED URINARY TRACT INFECTIONS
1997
Management of Influenza in Households: A Prospective, Randomized Comparison of Oseltamivir Treatment With or Without Postexposure Prophylaxis
2004
VIRAL SHEDDING IN CHILDREN WITH INFLUENZA VIRUS INFECTIONS TREATED WITH NEURAMINIDASE INHIBITORS
2005
Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing
2012 StandoutNobel
Severe Sepsis and Septic Shock
2013 Standout
Antiviral chemotherapeutic agents against respiratory viruses
2004
Oral oseltamivir treatment of influenza in children
2001
Antiviral agents active against influenza A viruses
2006
Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors
2015 StandoutNobel
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Metronidazole
1997
The Influence of Oseltamivir Treatment on the Risk of Stroke after Influenza Infection
2008
Treating hepatitis C
2005 StandoutNobel
Famciclovir treatment options for patients with frequent outbreaks of recurrent genital herpes: The RELIEF trial
2008
Drug-Induced Severe Skin Reactions
1995
Clinical Features of Influenza A Virus Infection in Older Hospitalized Persons
2002
Factors Influencing the Effectiveness of Oseltamivir and Amantadine for the Treatment of Influenza: A Multicenter Study from Japan of the 2002--2003 Influenza Season
2005
Effectiveness of neuraminidase inhibitors in treatment and prevention of influenza A and B: systematic review and meta-analyses of randomised controlled trials
2003
Medication Use and the Risk of Stevens–Johnson Syndrome or Toxic Epidermal Necrolysis
1995 Standout
Strategies in the design of antiviral drugs
2002
Near-patient assays for diagnosis of influenza virus infection in adult patients
2009
How were new medicines discovered?
2011 Standout
Vaccines for preventing influenza in healthy adults
2010
Genital herpes
2007
Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials
2015
Severe Adverse Cutaneous Reactions to Drugs
1994 Standout
Does Medicare Save Lives?*
2009 StandoutNobel
Uncomplicated Urinary Tract Infection
2012 Standout
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial
2010 Standout
Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children
2012
A Computationally Designed Hemagglutinin Stem-Binding Protein Provides In Vivo Protection from Influenza Independent of a Host Immune Response
2016 StandoutNobel
Preventing Nosocomial Influenza by Improving the Vaccine Acceptance Rate of Clinicians
2004
Immunomodulatory therapy for severe influenza
2011
Hospital-Acquired Infections Due to Gram-Negative Bacteria
2010 Standout
FluSTAR, A Novel Influenza Surveillance System: Outcomes from the 2005–2006 Flu Season
2007
Impact of Zanamivir on Antibiotic Use for Respiratory Events Following Acute Influenza in Adolescents and Adults
2000
Male Circumcision for the Prevention of HSV-2 and HPV Infections and Syphilis
2009 Standout
The ABC of clinical and experimental adjuvants—A brief overview
2009
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
2010
Theoretical Basis, Experimental Design, and Computerized Simulation of Synergism and Antagonism in Drug Combination Studies
2006 Standout
The acute respiratory distress syndrome
2012 Standout
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
2003 Standout
Nanobodies With In Vitro Neutralizing Activity Protect Mice Against H5N1 Influenza Virus Infection
2011
Epidemiology, microbiology, and treatment considerations for bacterial pneumonia complicating influenza
2012
Oral Oseltamivir Improves Pulmonary Function and Reduces Exacerbation Frequency for Influenza-Infected Children With Asthma
2005
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting
2015 Standout
Recognizing Influenza in Older Patients with Chronic Obstructive Pulmonary Disease Who Have Received Influenza Vaccine
2003
The use of antiviral agents for the management of severe influenza
2010
Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America
2019 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Ionic-Liquid-Mediated Extraction and Separation Processes for Bioactive Compounds: Past, Present, and Future Trends
2017 Standout
PRODUCTION AND ROLE OF INTERFERON IN PHYSIOLOGICAL CONDITIONS
1981
A Replication-Competent, Neuronal Spread-Defective, Live Attenuated Herpes Simplex Virus Type 1 Vaccine
2008
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Management of Influenza
2000
AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update
2006 Standout
Infectious Diseases Society of America Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria in Adults
2005 Standout
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Guidelines for the Primary Prevention of Stroke
2014 Standout
Chromone: A Valid Scaffold in Medicinal Chemistry
2014 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa
2018
Herpes Simplex Viruses
2002
Click Chemistry-Facilitated Structural Diversification of Nitrothiazoles, Nitrofurans, and Nitropyrroles Enhances Antimicrobial Activity against Giardia lamblia
2017 StandoutNobel
Oral Oseltamivir in Human Experimental Influenza B Infection
2000
Diagnosing COVID-19: The Disease and Tools for Detection
2020 Standout
The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America
2006 Standout
Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America
2010 Standout
Neuraminidase inhibitors for preventing and treating influenza in adults and children
2014
An HSV-2 nucleoside-modified mRNA genital herpes vaccine containing glycoproteins gC, gD, and gE protects mice against HSV-1 genital lesions and latent infection
2020 StandoutNobel
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
2002
Cyclopentane Neuraminidase Inhibitors with Potent In Vitro Anti-Influenza Virus Activities
2001
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
2018
The global and regional burden of genital ulcer disease due to herpes simplex virus: a natural history modelling study
2020
Influenza vaccines for preventing cardiovascular disease
2015
Microbial Biofilms: from Ecology to Molecular Genetics
2000 Standout
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
2013 Standout
Update on Tick-Borne Rickettsioses around the World: a Geographic Approach
2013 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations
2001
Delayed treatment with combinations of antiviral drugs in mice infected with herpes simplex virus and application of the median effect method of analysis
1986
Protein kinase in human plasma analogous to that present in control and interferon-treated HeLa cells
1981 StandoutNobel
Neuraminidase inhibitors for preventing and treating influenza in healthy adults
2006
Triple Combination of Oseltamivir, Amantadine, and Ribavirin Displays Synergistic Activity against Multiple Influenza Virus Strains In Vitro
2009
Nanobodies: Natural Single-Domain Antibodies
2013 Standout
Recurrence Rates in Genital Herpes after Symptomatic First-Episode Infection
1994
Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
2001 Standout
Works of F. Y. Aoki being referenced
Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial
2000
Clinic-Initiated, Twice-Daily Oral Famciclovir for Treatment of Recurrent Genital Herpes: A Randomized, Double-Blind, Controlled Trial
2005
Single-Day, Patient-Initiated Famciclovir Therapy for Recurrent Genital Herpes: A Randomized, Double-Blind, Placebo-Controlled Trial
2005
Prospects for Control of Herpes Simplex Virus Disease through Immunization
2000
Safety and Immunogenicity of Glycoprotein D--Adjuvant Genital Herpes Vaccine
2005
A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness
2011
Randomized, Double-Blind, Placebo-Controlled, Clinic-Initiated, Canadian Multicenter Trial of Topical Edoxudine 3.0% Cream in the Treatment of Recurrent Genital Herpes
1991
Early administration of oral oseltamivir increases the benefits of influenza treatment
2002
Influenza immunization: knowledge, attitude and behaviour of health care workers.
1994
Urine specimen collection with external devices for diagnosis of bacteriuria in elderly incontinent men
1988
Antiherpes effects and pharmacokinetic properties of 9-(4-hydroxybutyl) guanine and the (R) and (S) enantiomers of 9-(3,4-dihydroxybutyl)guanine
1985
Clinical Course of Recurrent Genital Herpes and Treatment with Foscarnet Cream: Results of a Canadian Multicenter Trial
1987
Immunologic studies in subjects with a serum sickness-like illness after immunization with human diploid cell rabies vaccine
1987
Effect of a Polynucleotide Interferon Inducer of Fungal Origin on Experimental Rhinovirus Infection in Humans
1978
Prospective, Randomized, Comparative Trials in the Therapy for Intraabdominal and Female Genital Tract Infections
1984